Advanced Filters
noise

Roeselare, Australia Clinical Trials

A listing of Roeselare, Australia clinical trials actively recruiting patients volunteers.

Found 64,712 clinical trials
M Melissa Hines, MD

Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products

Human gene therapy products are designed to achieve therapeutic effect through genetic modifications of human cells using retroviral or lentiviral vectors, resulting in permanent or long-acting changes in the human body. With this genetic modification comes risk of undesirable adverse events. Due to this risk, the Food and Drug Administration …

years of age All Phase N/A
S Sammi Kile, MS

The Fibrodysplasia Ossificans Progressiva (FOP) Registry

The Fibrodysplasia Ossificans Progressiva (FOP) Registry is a global, non-interventional, voluntary database that captures demographic and disease data directly from FOP patients and their caregivers via a secure, web-based patient portal. A physician portal (in development) will allow physicians to enter clinical data about their patients. The objectives are to …

years of age All Phase N/A
J Jill A Harsch, BS

Glowing and Expecting Follow Up

This study will help us learn more about how a mother's health during pregnancy may influence her child's growth and development later in life.

5 - 14 years of age All Phase N/A
F Florim Cuculi, MD

CARDSUP - SWISS Circulatory Support Registry

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of …

18 years of age All Phase N/A
M Megan Rowland

Coronary Microvascular Disease (CMD) Registry

The purpose of this project is to provide appropriate administrative and technical supports for the warehousing and use of a database of patients with coronary microvascular disease (CMD). This protocol will outline the process for identification and capture of data, storage, as well as data use and sharing internally and …

18 years of age All Phase N/A
M Margaret P Collins, PhD

Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

Background: Over 26 million Americans have chronic obstructive pulmonary disease (COPD), which is the third leading cause of death in the United States. Unfortunately, few patients receive proven therapies and many receive therapies known to have safer alternatives. One major reason is the competing demands of primary care providers (PCPs) …

years of age All Phase N/A

The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer

The majority of early breast cancer patients are treated with adjuvant radiation therapy (RT) as part of their multimodal therapy. The aim of the RT is to lower the risk of local, regional and distant failure and improve survival. Modern RT is been provided with photon therapy. Now, more proton …

18 years of age All Phase N/A
J Juliana Laze

Risk Factors for Sudden Unexplained Death in Epilepsy

The main purpose of this study is to develop a North American registry for SUDEP cases; requesting family members of epilepsy patients who died suddenly of unclear causes (SUDEP) to contact the study team. The family members who decide to participate in the study will be asked to complete a …

years of age All Phase N/A
M Maria Pirozzoli

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

The primary purpose of the study is to evaluate the safety and tolerability of multiple intravenous (IV) doses of DYNE-101 administered to participants with Myotonic Dystrophy Type 1 (DM1). The study consists of 4 periods: A Screening Period (up to 8 weeks), a Placebo-Controlled Period (24 weeks), a Treatment Period …

18 - 65 years of age All Phase 1/2

Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units

In intensive care units (ICUs), around 20% of patients experience respiratory failure after planned extubation. Nearly 40-50% of them eventually require reintubation with subsequently high mortality rates reaching 30-40%. NIV used as rescue therapy to treat post-extubation respiratory failure could increase the risk of death. However, NIV may avoid reintubation …

18 years of age All Phase N/A

Simplify language using AI